However, this particular study did not directly assess ICAM-1 status in either the lymph node metastases or the DTCs, and no correlation was found between MHC I/ICAM-1 negativity and DTC positivity in bone marrow. The gene discussed is ICAM1; the disease is metastatic malignant neoplasm in the lymph nodes.